OrbiMed Capital GP VI LLC
Insider CIK 1682115 · AVDR 10% owner · CNST 10% owner · KALA 10% owner · SYBX Director · NPCE 10% owner · GRAY 10% owner · TPTX Director · SCPH 10% owner · STDY 10% owner · ALPN Director, 10% owner · VRNA Director · NXTC Director, 10% owner · LOGC Director, 10% owner · SBTX Director, 10% owner · PRLD Director, 10% owner · EWTX Director, 10% owner · PRVL Director, 10% owner · TORC Director, 10% owner · CMPX Director, 10% owner · TSBX Director, 10% owner · SWTX 10% owner · ETNB Director, 10% owner · ORIC Director, 10% owner · IRON Director, 10% owner · IKNA Director · CTIC 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PRLD Prelude Therapeutics Inc | P Buy | 2026-04-21 | 2026-04-23 | 1,126,126 | $4.44 | $5.00M | 1,126,126 | SEC↗ |
| PRLD Prelude Therapeutics Inc | P Buy | 2026-04-21 | 2026-04-23 | 1,689,189 | $4.44 | $7.50M | 11,808,945 | SEC↗ |
| IMA ImageneBio, Inc. | P Buy deriv | 2026-04-14 | 2026-04-16 | 336,603 | — | $0 | 336,603 | SEC↗ |
| IMA ImageneBio, Inc. | P Buy deriv | 2026-04-14 | 2026-04-16 | 384,689 | — | $0 | 384,689 | SEC↗ |
| ACET Adicet Bio, Inc. | S Sale | 2026-04-08 | 2026-04-09 | 40,416 | $6.52 | $263.5K | 0 | SEC↗ |
| ACET Adicet Bio, Inc. | S Sale | 2026-04-08 | 2026-04-09 | 32,523 | $6.29 | $204.6K | 0 | SEC↗ |
| ACET Adicet Bio, Inc. | S Sale | 2026-04-07 | 2026-04-09 | 2,400 | $6.38 | $15.3K | 32,523 | SEC↗ |
| ACET Adicet Bio, Inc. | S Sale | 2026-04-07 | 2026-04-09 | 29,319 | $6.53 | $191.5K | 34,923 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2025-10-08 | 2025-10-10 | 3,500,000 | $1.00 | $3.50M | 4,490,254 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2025-10-08 | 2025-10-10 | 1,500,000 | $1.00 | $1.50M | 9,026,359 | SEC↗ |
| TSBX Turnstone Biologics Corp. | U Tender | 2025-08-08 | 2025-08-12 | 3,099,265 | — | $0 | 0 | SEC↗ |
| IKNA ImageneBio, Inc. | A Award | 2025-07-25 | 2025-07-30 | 83,611 | $2.49 | $208.2K | 287,885 | SEC↗ |
| NPCE NeuroPace Inc | S Sale | 2025-05-14 | 2025-05-16 | 134,136 | $15.83 | $2.12M | 3,272,199 | SEC↗ |
| NPCE NeuroPace Inc | S Sale | 2025-05-14 | 2025-05-16 | 34,000 | $15.94 | $542.0K | 3,238,199 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | S Sale | 2025-04-09 | 2025-04-11 | 3,571,428 | $1.59 | $5.68M | 0 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | P Buy | 2025-04-03 | 2025-04-04 | 372,578 | $20.13 | $7.50M | 14,809,075 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | P Buy | 2025-04-03 | 2025-04-04 | 124,193 | $20.13 | $2.50M | 443,792 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-24 | 2025-03-26 | 1,956 | $54.11 | $105.8K | 482,308 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-24 | 2025-03-26 | 3,026 | $54.11 | $163.7K | 746,171 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-24 | 2025-03-26 | 756 | $54.11 | $40.9K | 186,541 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-21 | 2025-03-21 | 1,320 | $54.00 | $71.3K | 187,297 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-21 | 2025-03-21 | 5,279 | $54.00 | $285.1K | 749,197 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-21 | 2025-03-21 | 3,412 | $54.00 | $184.2K | 484,264 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-20 | 2025-03-21 | 364 | $54.01 | $19.7K | 188,617 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-20 | 2025-03-21 | 1,457 | $54.01 | $78.7K | 754,476 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-20 | 2025-03-21 | 941 | $54.01 | $50.8K | 487,676 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-19 | 2025-03-21 | 5,228 | $54.02 | $282.4K | 188,981 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-19 | 2025-03-21 | 20,911 | $54.02 | $1.13M | 755,933 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-19 | 2025-03-21 | 13,517 | $54.02 | $730.2K | 488,617 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-12 | 2025-03-12 | 10,733 | $54.44 | $584.3K | 194,209 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-12 | 2025-03-12 | 603 | $55.05 | $33.2K | 529,884 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-12 | 2025-03-12 | 933 | $55.05 | $51.4K | 819,774 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-12 | 2025-03-12 | 233 | $55.05 | $12.8K | 204,942 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-12 | 2025-03-12 | 42,930 | $54.44 | $2.34M | 776,844 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-12 | 2025-03-12 | 27,750 | $54.44 | $1.51M | 502,134 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-11 | 2025-03-12 | 9,222 | $54.01 | $498.1K | 530,487 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-11 | 2025-03-12 | 14,267 | $54.01 | $770.6K | 820,707 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-11 | 2025-03-12 | 3,567 | $54.01 | $192.7K | 205,175 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-10 | 2025-03-12 | 68,766 | $54.29 | $3.73M | 539,845 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-10 | 2025-03-12 | 106,384 | $54.29 | $5.78M | 835,185 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-10 | 2025-03-12 | 26,596 | $54.29 | $1.44M | 208,795 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-10 | 2025-03-12 | 136 | $55.01 | $7.5K | 539,709 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-10 | 2025-03-12 | 211 | $55.01 | $11.6K | 834,974 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-10 | 2025-03-12 | 53 | $55.01 | $2.9K | 208,742 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-08-26 | 2024-08-28 | 83,695 | $13.00 | $1.09M | 0 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-08-23 | 2024-08-23 | 69,500 | $13.03 | $905.6K | 83,695 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-08-22 | 2024-08-23 | 391,482 | $12.94 | $5.07M | 153,195 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-08-21 | 2024-08-23 | 13,300 | $14.61 | $194.3K | 544,677 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-08-21 | 2024-08-23 | 394,400 | $13.52 | $5.33M | 557,977 | SEC↗ |
| SCPH scPharmaceuticals Inc. | P Buy | 2024-08-13 | 2024-08-15 | 478,342 | $4.00 | $1.91M | 5,806,670 | SEC↗ |
| SCPH scPharmaceuticals Inc. | P Buy | 2024-08-13 | 2024-08-15 | 21,658 | $4.00 | $86.6K | 252,858 | SEC↗ |
| IRON Disc Medicine, Inc. | P Buy | 2024-06-17 | 2024-06-20 | 43,944 | $36.00 | $1.58M | 941,569 | SEC↗ |
| IRON Disc Medicine, Inc. | P Buy | 2024-06-17 | 2024-06-20 | 10,986 | $36.00 | $395.5K | 235,391 | SEC↗ |
| IRON Disc Medicine, Inc. | P Buy | 2024-06-17 | 2024-06-20 | 28,404 | $36.00 | $1.02M | 608,611 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | U Tender | 2024-05-18 | 2024-05-20 | 264,315 | — | $0 | 0 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | U Tender | 2024-05-18 | 2024-05-20 | 2,416,181 | — | $0 | 0 | SEC↗ |
| NPCE NeuroPace Inc | S Sale | 2024-05-03 | 2024-05-03 | 4,674 | $14.03 | $65.6K | 3,406,335 | SEC↗ |
| NPCE NeuroPace Inc | S Sale | 2024-05-02 | 2024-05-03 | 8,842 | $14.01 | $123.9K | 3,411,009 | SEC↗ |
| NPCE NeuroPace Inc | S Sale | 2024-05-01 | 2024-05-03 | 15,690 | $14.02 | $220.0K | 3,419,851 | SEC↗ |
| NPCE NeuroPace Inc | S Sale | 2024-04-24 | 2024-04-26 | 1,781 | $14.06 | $25.0K | 3,435,541 | SEC↗ |
| NPCE NeuroPace Inc | S Sale | 2024-04-23 | 2024-04-23 | 21,791 | $14.29 | $311.4K | 3,437,322 | SEC↗ |
| NPCE NeuroPace Inc | S Sale | 2024-04-22 | 2024-04-23 | 24,609 | $14.05 | $345.8K | 3,459,113 | SEC↗ |
| NPCE NeuroPace Inc | S Sale | 2024-04-19 | 2024-04-23 | 18,253 | $14.02 | $255.9K | 3,483,722 | SEC↗ |
| NPCE NeuroPace Inc | S Sale | 2024-04-18 | 2024-04-18 | 2,623 | $14.06 | $36.9K | 3,501,975 | SEC↗ |
| NPCE NeuroPace Inc | S Sale | 2024-04-17 | 2024-04-18 | 300 | $14.15 | $4.2K | 3,504,598 | SEC↗ |
| NPCE NeuroPace Inc | S Sale | 2024-04-16 | 2024-04-18 | 14,069 | $14.01 | $197.1K | 3,504,898 | SEC↗ |
| NPCE NeuroPace Inc | S Sale | 2024-04-12 | 2024-04-15 | 23,101 | $14.42 | $333.1K | 3,518,967 | SEC↗ |
| NPCE NeuroPace Inc | S Sale | 2024-04-11 | 2024-04-15 | 461,899 | $14.49 | $6.69M | 3,542,068 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2024-01-25 | 2024-01-26 | 1,841,100 | $2.40 | $4.42M | 7,526,359 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2024-01-25 | 2024-01-26 | 1,041,700 | $2.40 | $2.50M | 1,255,985 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2024-01-25 | 2024-01-26 | 242,200 | $2.40 | $581.3K | 990,254 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | P Buy | 2024-01-23 | 2024-01-25 | 454,545 | $11.00 | $5.00M | 14,436,497 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | X Exercise deriv | 2024-01-11 | 2024-01-16 | 145,251 | — | $0 | 0 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | X Exercise | 2024-01-11 | 2024-01-16 | 145,251 | $12.74 | $1.85M | 2,416,181 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | S Sale | 2023-12-28 | 2023-12-29 | 3,128 | $19.82 | $62.0K | 403,481 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | S Sale | 2023-12-28 | 2023-12-29 | 1,195,683 | $18.32 | $21.90M | 2,270,930 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | S Sale | 2023-12-28 | 2023-12-29 | 139,166 | $18.32 | $2.55M | 264,315 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | S Sale | 2023-12-28 | 2023-12-29 | 26,872 | $19.82 | $532.6K | 3,466,613 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | S Sale | 2023-12-27 | 2023-12-29 | 162,576 | $19.96 | $3.25M | 3,493,485 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | S Sale | 2023-12-27 | 2023-12-29 | 18,922 | $19.96 | $377.7K | 406,609 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise deriv | 2023-12-18 | 2023-12-20 | 1,724 | — | $0 | 0 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-18 | 2023-12-20 | 1,724 | $59.24 | $102.1K | 0 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise | 2023-12-18 | 2023-12-20 | 1,724 | $38.00 | $65.5K | 1,724 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-14 | 2023-12-14 | 100 | $57.73 | $5.8K | 1,126,125 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-14 | 2023-12-14 | 100 | $57.73 | $5.8K | 727,807 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-14 | 2023-12-15 | 228,500 | $56.75 | $12.97M | 897,625 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-14 | 2023-12-15 | 57,100 | $56.75 | $3.24M | 224,405 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-14 | 2023-12-15 | 147,600 | $56.75 | $8.38M | 580,207 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-13 | 2023-12-14 | 36,400 | $58.56 | $2.13M | 727,907 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-13 | 2023-12-14 | 14,100 | $58.56 | $825.7K | 281,505 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-13 | 2023-12-14 | 56,200 | $58.56 | $3.29M | 1,126,225 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-12 | 2023-12-14 | 3,600 | $60.16 | $216.6K | 295,605 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-12 | 2023-12-14 | 9,300 | $60.16 | $559.5K | 764,307 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-12 | 2023-12-14 | 14,400 | $60.16 | $866.3K | 1,182,425 | SEC↗ |
| NPCE NeuroPace Inc | S Sale | 2023-10-03 | 2023-10-04 | 700 | $9.02 | $6.3K | 4,003,967 | SEC↗ |
| NPCE NeuroPace Inc | S Sale | 2023-10-02 | 2023-10-04 | 7,614 | $9.08 | $69.1K | 4,004,667 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | P Buy | 2023-08-29 | 2023-08-31 | 500,000 | $6.20 | $3.10M | 8,019,187 | SEC↗ |
| IKNA Ikena Oncology, Inc. | A Award deriv | 2023-08-04 | 2023-09-14 | 353,192 | — | $0 | 353,192 | SEC↗ |
| IKNA Ikena Oncology, Inc. | A Award deriv | 2023-08-04 | 2023-09-21 | 353,192 | — | $0 | 353,192 | SEC↗ |
| IKNA Ikena Oncology, Inc. | A Award | 2023-08-04 | 2023-09-14 | 153,121 | — | $0 | 2,251,218 | SEC↗ |
| IKNA Ikena Oncology, Inc. | A Award | 2023-08-04 | 2023-09-21 | 153,121 | — | $0 | 5,582,144 | SEC↗ |
| TSBX Turnstone Biologics Corp. | C Conversion deriv | 2023-07-20 | 2023-07-24 | 1,249,829 | — | $0 | 0 | SEC↗ |
| TSBX Turnstone Biologics Corp. | C Conversion deriv | 2023-07-20 | 2023-07-24 | 229,158 | — | $0 | 0 | SEC↗ |
| TSBX Turnstone Biologics Corp. | C Conversion deriv | 2023-07-20 | 2023-07-24 | 266,240 | — | $0 | 0 | SEC↗ |
| TSBX Turnstone Biologics Corp. | C Conversion deriv | 2023-07-20 | 2023-07-24 | 937,372 | — | $0 | 0 | SEC↗ |
| TSBX Turnstone Biologics Corp. | P Buy | 2023-07-20 | 2023-07-24 | 416,666 | $12.00 | $5.00M | 3,099,265 | SEC↗ |
| TSBX Turnstone Biologics Corp. | C Conversion | 2023-07-20 | 2023-07-24 | 2,682,599 | — | $0 | 2,682,599 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2023-06-27 | 2023-06-29 | 125,000 | $2.09 | $261.2K | 1,027,885 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2023-06-27 | 2023-06-29 | 250,000 | $2.09 | $522.5K | 646,657 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2023-06-27 | 2023-06-29 | 442,000 | $2.09 | $923.8K | 5,685,259 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2023-06-27 | 2023-06-29 | 58,000 | $2.09 | $121.2K | 748,054 | SEC↗ |
| PRLD Prelude Therapeutics Inc | P Buy | 2023-05-22 | 2023-05-24 | 869,565 | $5.75 | $5.00M | 10,119,756 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2023-05-15 | 2023-05-15 | 14,400 | $21.96 | $316.2K | 4,123,091 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2023-05-15 | 2023-05-15 | 345,313 | $20.00 | $6.91M | 3,777,778 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2023-05-12 | 2023-05-15 | 43,200 | $21.64 | $934.8K | 4,137,491 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2023-05-11 | 2023-05-15 | 80,000 | $22.26 | $1.78M | 4,180,691 | SEC↗ |
| IRON Disc Medicine, Inc. | P Buy | 2023-02-15 | 2023-02-17 | 37,049 | $23.00 | $852.1K | 773,607 | SEC↗ |
| IRON Disc Medicine, Inc. | P Buy | 2023-02-15 | 2023-02-17 | 57,318 | $23.00 | $1.32M | 1,196,825 | SEC↗ |
| IRON Disc Medicine, Inc. | P Buy | 2023-02-15 | 2023-02-17 | 14,329 | $23.00 | $329.6K | 299,205 | SEC↗ |
| IRON Disc Medicine, Inc. | J Other | 2022-12-29 | 2023-01-03 | 284,876 | — | $0 | 284,876 | SEC↗ |
| IRON Disc Medicine, Inc. | J Other | 2022-12-29 | 2023-01-03 | 153,936 | — | $0 | 736,558 | SEC↗ |
| IRON Disc Medicine, Inc. | J Other | 2022-12-29 | 2023-01-03 | 582,622 | — | $0 | 582,622 | SEC↗ |
| IRON Disc Medicine, Inc. | J Other | 2022-12-29 | 2023-01-03 | 1,139,507 | — | $0 | 1,139,507 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2022-12-23 | 2022-12-27 | 961,328 | $22.27 | $21.41M | 35,294,568 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2022-12-23 | 2022-12-27 | 1,116,048 | $23.23 | $25.93M | 34,178,520 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2022-12-23 | 2022-12-27 | 92,992 | $24.11 | $2.24M | 34,085,528 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2022-12-22 | 2022-12-27 | 684,696 | $22.07 | $15.11M | 36,255,896 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2022-12-22 | 2022-12-27 | 3,284,800 | $21.71 | $71.31M | 36,940,592 | SEC↗ |
| SCPH scPharmaceuticals Inc. | P Buy | 2022-11-25 | 2022-11-29 | 762,380 | $5.25 | $4.00M | 5,328,328 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | P Buy | 2022-09-16 | 2022-09-16 | 484,496 | $10.32 | $5.00M | 13,981,952 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2022-09-12 | 2022-09-14 | 123,897 | $31.96 | $3.96M | 5,629,842 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2022-09-12 | 2022-09-14 | 30,000 | $31.98 | $959.4K | 5,599,842 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2022-08-09 | 2022-08-10 | 69,568 | $37.47 | $2.61M | 5,753,739 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2022-08-08 | 2022-08-10 | 205,000 | $38.33 | $7.86M | 5,823,307 | SEC↗ |
| IKNA Ikena Oncology, Inc. | P Buy | 2022-06-24 | 2022-06-24 | 96,035 | $5.37 | $515.7K | 2,098,097 | SEC↗ |
| IKNA Ikena Oncology, Inc. | P Buy | 2022-06-24 | 2022-06-24 | 65,965 | $4.37 | $288.3K | 2,002,062 | SEC↗ |
| IKNA Ikena Oncology, Inc. | P Buy | 2022-06-23 | 2022-06-24 | 23,419 | $3.71 | $86.9K | 1,936,097 | SEC↗ |
| IKNA Ikena Oncology, Inc. | P Buy | 2022-06-22 | 2022-06-24 | 66,806 | $3.55 | $237.2K | 1,912,678 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | P Buy | 2022-05-18 | 2022-05-20 | 138,000 | $7.21 | $995.0K | 13,497,456 | SEC↗ |
| ETNB 89bio, Inc. | S Sale | 2022-01-26 | 2022-01-27 | 10,740 | $8.38 | $90.0K | 1,829,436 | SEC↗ |
| ETNB 89bio, Inc. | S Sale | 2022-01-26 | 2022-01-27 | 10,742 | $8.38 | $90.0K | 1,829,433 | SEC↗ |
| ETNB 89bio, Inc. | S Sale | 2022-01-25 | 2022-01-27 | 24,546 | $8.40 | $206.2K | 1,840,175 | SEC↗ |
| ETNB 89bio, Inc. | S Sale | 2022-01-25 | 2022-01-27 | 24,545 | $8.40 | $206.2K | 1,840,176 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award | 2021-12-10 | 2021-12-14 | 214,285 | $14.00 | $3.00M | 242,285 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | P Buy | 2021-09-17 | 2021-09-21 | 585,106 | $9.40 | $5.50M | 3,656,061 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | P Buy | 2021-09-17 | 2021-09-21 | 425,531 | $9.40 | $4.00M | 425,531 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2021-07-01 | 2021-07-06 | 15,959 | $85.01 | $1.36M | 6,028,307 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2021-06-28 | 2021-06-30 | 6,502 | $85.17 | $553.8K | 6,044,266 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2021-06-25 | 2021-06-25 | 22,334 | $85.14 | $1.90M | 6,050,768 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2021-06-24 | 2021-06-25 | 34,200 | $85.22 | $2.91M | 6,073,102 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2021-06-23 | 2021-06-25 | 100 | $85.00 | $8.5K | 6,107,302 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2021-06-10 | 2021-06-14 | 30,852 | $85.09 | $2.63M | 6,107,402 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2021-06-09 | 2021-06-09 | 5,049 | $85.33 | $430.8K | 6,138,254 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2021-06-08 | 2021-06-09 | 42,633 | $85.37 | $3.64M | 6,143,303 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2021-06-07 | 2021-06-09 | 371 | $84.90 | $31.5K | 6,185,936 | SEC↗ |
| NPCE NeuroPace Inc | C Conversion deriv | 2021-04-26 | 2021-04-26 | 171,895 | — | $0 | 0 | SEC↗ |
| NPCE NeuroPace Inc | C Conversion deriv | 2021-04-26 | 2021-04-26 | 3,605,386 | — | $0 | 0 | SEC↗ |
| NPCE NeuroPace Inc | C Conversion | 2021-04-26 | 2021-04-26 | 3,777,281 | — | $0 | 4,012,281 | SEC↗ |
| NPCE NeuroPace Inc | P Buy | 2021-04-21 | 2021-04-23 | 235,000 | $17.00 | $4.00M | 235,000 | SEC↗ |
| SYBX SYNLOGIC, INC. | A Award | 2021-04-20 | 2021-04-22 | 1,666,666 | $3.00 | $5.00M | 3,696,662 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion deriv | 2021-03-30 | 2021-04-01 | 328,907 | — | $0 | 0 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion deriv | 2021-03-30 | 2021-04-01 | 920,484 | — | $0 | 0 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion deriv | 2021-03-30 | 2021-04-01 | 806,752 | — | $0 | 0 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion deriv | 2021-03-30 | 2021-04-01 | 2,257,785 | — | $0 | 0 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion deriv | 2021-03-30 | 2021-04-01 | 680,766 | — | $0 | 0 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion deriv | 2021-03-30 | 2021-04-01 | 1,905,201 | — | $0 | 0 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion deriv | 2021-03-30 | 2021-04-01 | 68,978 | — | $0 | 0 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion deriv | 2021-03-30 | 2021-04-01 | 130,924 | — | $0 | 0 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion deriv | 2021-03-30 | 2021-04-13 | 2,034,708 | — | $0 | 0 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion deriv | 2021-03-30 | 2021-04-13 | 551,259 | — | $0 | 0 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion deriv | 2021-03-30 | 2021-04-13 | 2,411,260 | — | $0 | 0 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion deriv | 2021-03-30 | 2021-04-13 | 653,277 | — | $0 | 0 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion deriv | 2021-03-30 | 2021-04-13 | 983,055 | — | $0 | 0 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion deriv | 2021-03-30 | 2021-04-13 | 266,336 | — | $0 | 0 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion deriv | 2021-03-30 | 2021-04-13 | 157,288 | — | $0 | 0 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion deriv | 2021-03-30 | 2021-04-13 | 42,614 | — | $0 | 0 | SEC↗ |
| IKNA Ikena Oncology, Inc. | P Buy | 2021-03-30 | 2021-04-01 | 375,000 | $16.00 | $6.00M | 2,191,425 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion | 2021-03-30 | 2021-04-01 | 1,816,425 | — | $0 | 1,816,425 | SEC↗ |
| IKNA Ikena Oncology, Inc. | P Buy | 2021-03-30 | 2021-04-01 | 48,400 | $16.00 | $774.4K | 117,378 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion | 2021-03-30 | 2021-04-01 | 5,083,470 | — | $0 | 5,083,470 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion | 2021-03-30 | 2021-04-01 | 130,924 | — | $0 | 130,924 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion | 2021-03-30 | 2021-04-01 | 68,978 | — | $0 | 68,978 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion | 2021-03-30 | 2021-04-13 | 1,470,872 | — | $0 | 1,470,872 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion | 2021-03-30 | 2021-04-13 | 42,614 | — | $0 | 42,614 | SEC↗ |
| IKNA Ikena Oncology, Inc. | P Buy | 2021-03-30 | 2021-04-13 | 48,400 | $16.00 | $774.4K | 91,014 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion | 2021-03-30 | 2021-04-13 | 5,429,023 | — | $0 | 5,429,023 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion | 2021-03-30 | 2021-04-13 | 157,288 | — | $0 | 157,288 | SEC↗ |
| IKNA Ikena Oncology, Inc. | P Buy | 2021-03-30 | 2021-04-13 | 375,000 | $16.00 | $6.00M | 1,845,872 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | C Conversion deriv | 2021-03-30 | 2021-03-31 | 1,668,350 | — | $0 | 0 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | C Conversion deriv | 2021-03-30 | 2021-03-31 | 1,301,626 | — | $0 | 0 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | C Conversion deriv | 2021-03-30 | 2021-03-31 | 272,724 | — | $0 | 0 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | C Conversion deriv | 2021-03-30 | 2021-03-31 | 8,187,100 | — | $0 | 0 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | C Conversion deriv | 2021-03-30 | 2021-03-31 | 1,572,960 | — | $0 | 0 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-03-30 | 2021-03-31 | 27,869 | $23.93 | $666.9K | 2,212,571 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | P Buy | 2021-03-30 | 2021-03-31 | 46,875 | $16.00 | $750.0K | 319,599 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | P Buy | 2021-03-30 | 2021-03-31 | 312,500 | $16.00 | $5.00M | 13,359,456 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | C Conversion | 2021-03-30 | 2021-03-31 | 272,724 | — | $0 | 272,724 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | C Conversion | 2021-03-30 | 2021-03-31 | 12,730,036 | — | $0 | 13,046,956 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-03-29 | 2021-03-31 | 75,555 | $23.31 | $1.76M | 2,240,440 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-03-26 | 2021-03-26 | 27,816 | $23.88 | $664.2K | 2,315,995 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-03-25 | 2021-03-26 | 51,523 | $24.70 | $1.27M | 2,343,811 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-03-24 | 2021-03-26 | 32,959 | $24.80 | $817.4K | 2,395,334 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-03-23 | 2021-03-23 | 3,992 | $24.32 | $97.1K | 2,428,293 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-03-22 | 2021-03-23 | 7,673 | $26.47 | $203.1K | 2,432,285 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-03-19 | 2021-03-23 | 21,275 | $26.47 | $563.1K | 2,439,958 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-03-18 | 2021-03-18 | 6,059 | $28.03 | $169.8K | 2,461,233 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-03-17 | 2021-03-18 | 18,790 | $28.43 | $534.2K | 2,467,292 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-03-16 | 2021-03-18 | 41,353 | $27.72 | $1.15M | 2,486,082 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-03-15 | 2021-03-15 | 89,210 | $29.14 | $2.60M | 2,527,435 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-03-12 | 2021-03-15 | 90,521 | $30.29 | $2.74M | 2,616,645 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-03-11 | 2021-03-15 | 58,551 | $33.04 | $1.93M | 2,707,166 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2021-03-01 | 2021-03-03 | 1,220,000 | $83.19 | $101.49M | 6,186,307 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award | 2021-02-12 | 2021-02-18 | 420,299 | $13.00 | $5.46M | 5,243,259 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award | 2021-02-12 | 2021-02-18 | 104,050 | $13.00 | $1.35M | 396,657 | SEC↗ |
| PRVL Prevail Therapeutics Inc. | U Tender | 2021-01-22 | 2021-01-26 | 13,822,463 | — | $0 | 0 | SEC↗ |
| PRLD Prelude Therapeutics Inc | P Buy deriv | 2021-01-11 | 2021-01-12 | 41,700 | $60.00 | $2.50M | 5,596,886 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | S Sale | 2021-01-07 | 2021-01-11 | 2,000,000 | $3.50 | $7.00M | 7,520,600 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | S Sale | 2020-12-28 | 2020-12-30 | 600,000 | $14.25 | $8.55M | 3,070,955 | SEC↗ |
| IKNA Ikena Oncology, Inc. | A Award deriv | 2020-12-21 | 2021-04-01 | 1,430,103 | $1.40 | $2.00M | 1,430,103 | SEC↗ |
| IKNA Ikena Oncology, Inc. | A Award deriv | 2020-12-21 | 2021-04-01 | 8,938,148 | $1.40 | $12.51M | 8,938,148 | SEC↗ |
| IKNA Ikena Oncology, Inc. | A Award deriv | 2020-12-21 | 2021-04-13 | 8,938,148 | $1.40 | $12.51M | 8,938,148 | SEC↗ |
| IKNA Ikena Oncology, Inc. | A Award deriv | 2020-12-21 | 2021-04-13 | 1,430,103 | $1.40 | $2.00M | 1,430,103 | SEC↗ |
| SBTX Silverback Therapeutics, I | C Conversion deriv | 2020-12-08 | 2020-12-08 | 12,857,142 | — | $0 | 0 | SEC↗ |
| SBTX Silverback Therapeutics, I | C Conversion deriv | 2020-12-08 | 2020-12-08 | 3,918,279 | — | $0 | 0 | SEC↗ |
| SBTX Silverback Therapeutics, I | C Conversion deriv | 2020-12-08 | 2020-12-08 | 9,259,259 | — | $0 | 0 | SEC↗ |
| SBTX Silverback Therapeutics, I | C Conversion | 2020-12-08 | 2020-12-08 | 2,493,741 | — | $0 | 6,463,901 | SEC↗ |
| SBTX Silverback Therapeutics, I | C Conversion | 2020-12-08 | 2020-12-08 | 1,055,287 | — | $0 | 7,519,188 | SEC↗ |
| SBTX Silverback Therapeutics, I | P Buy | 2020-12-08 | 2020-12-08 | 952,377 | $21.00 | $20.00M | 952,377 | SEC↗ |
| SBTX Silverback Therapeutics, I | C Conversion | 2020-12-08 | 2020-12-08 | 3,462,737 | — | $0 | 3,970,160 | SEC↗ |
| SBTX Silverback Therapeutics, I | P Buy | 2020-12-08 | 2020-12-08 | 238,100 | $21.00 | $5.00M | 507,423 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | P Buy | 2020-10-01 | 2020-10-05 | 545,974 | $6.00 | $3.28M | 3,524,997 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | P Buy | 2020-10-01 | 2020-10-05 | 296,296 | $6.00 | $1.78M | 296,296 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | P Buy | 2020-10-01 | 2020-10-05 | 639,212 | $6.00 | $3.84M | 4,126,972 | SEC↗ |
| GRAY GRAYBUG VISION, INC. | C Conversion deriv | 2020-09-29 | 2020-09-29 | 846,574 | — | $0 | 0 | SEC↗ |
| GRAY GRAYBUG VISION, INC. | C Conversion deriv | 2020-09-29 | 2020-09-29 | 2,754,273 | — | $0 | 0 | SEC↗ |
| PRLD Prelude Therapeutics Inc | C Conversion deriv | 2020-09-29 | 2020-09-29 | 5,555,186 | — | $0 | 5,555,186 | SEC↗ |
| PRLD Prelude Therapeutics Inc | C Conversion deriv | 2020-09-29 | 2020-09-29 | 3,294,743 | — | $0 | 0 | SEC↗ |
| PRLD Prelude Therapeutics Inc | C Conversion deriv | 2020-09-29 | 2020-09-29 | 2,196,494 | — | $0 | 0 | SEC↗ |
| PRLD Prelude Therapeutics Inc | C Conversion deriv | 2020-09-29 | 2020-09-29 | 4,418,186 | — | $0 | 0 | SEC↗ |
| PRLD Prelude Therapeutics Inc | C Conversion deriv | 2020-09-29 | 2020-09-29 | 2,945,458 | — | $0 | 0 | SEC↗ |
| PRLD Prelude Therapeutics Inc | C Conversion deriv | 2020-09-29 | 2020-09-29 | 619,850 | — | $0 | 0 | SEC↗ |
| PRLD Prelude Therapeutics Inc | C Conversion deriv | 2020-09-29 | 2020-09-29 | 413,234 | — | $0 | 0 | SEC↗ |
| GRAY GRAYBUG VISION, INC. | C Conversion | 2020-09-29 | 2020-09-29 | 3,600,847 | — | $0 | 4,163,347 | SEC↗ |
| PRLD Prelude Therapeutics Inc | C Conversion | 2020-09-29 | 2020-09-29 | 8,332,779 | — | $0 | 9,250,191 | SEC↗ |
| GRAY GRAYBUG VISION, INC. | P Buy | 2020-09-25 | 2020-09-29 | 562,500 | $16.00 | $9.00M | 562,500 | SEC↗ |
| PRLD Prelude Therapeutics Inc | P Buy | 2020-09-25 | 2020-09-29 | 526,300 | $19.00 | $10.00M | 526,300 | SEC↗ |
| PRLD Prelude Therapeutics Inc | P Buy | 2020-09-25 | 2020-09-29 | 710,500 | $19.00 | $13.50M | 917,412 | SEC↗ |
| ETNB 89bio, Inc. | S Sale | 2020-09-21 | 2020-09-23 | 137,500 | $28.00 | $3.85M | 1,864,721 | SEC↗ |
| ETNB 89bio, Inc. | S Sale | 2020-09-21 | 2020-09-23 | 137,500 | $28.00 | $3.85M | 1,864,721 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2020-09-17 | 2020-09-17 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2020-09-17 | 2020-09-17 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award | 2020-09-15 | 2020-09-17 | 292,607 | — | $0 | 292,607 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award | 2020-09-15 | 2020-09-17 | 902,885 | — | $0 | 902,855 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award | 2020-09-15 | 2020-09-17 | 4,822,960 | — | $0 | 4,822,960 | SEC↗ |
| PRLD Prelude Therapeutics Inc | P Buy deriv | 2020-08-21 | 2020-09-30 | 1,033,084 | — | $0 | 1,033,084 | SEC↗ |
| SCPH scPharmaceuticals Inc. | P Buy | 2020-05-21 | 2020-05-26 | 231,200 | $8.65 | $2.00M | 231,200 | SEC↗ |
| SCPH scPharmaceuticals Inc. | P Buy | 2020-05-21 | 2020-05-26 | 1,156,083 | $8.65 | $10.00M | 4,565,948 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | C Conversion deriv | 2020-04-28 | 2020-04-28 | 236,111 | — | $0 | 0 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | C Conversion deriv | 2020-04-28 | 2020-04-28 | 1,875,000 | — | $0 | 0 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | C Conversion deriv | 2020-04-28 | 2020-04-28 | 373,356 | — | $0 | 0 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | C Conversion | 2020-04-28 | 2020-04-28 | 236,111 | — | $0 | 2,765,717 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | C Conversion | 2020-04-28 | 2020-04-28 | 1,875,000 | — | $0 | 2,156,250 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | C Conversion | 2020-04-28 | 2020-04-28 | 373,356 | — | $0 | 2,529,606 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | P Buy | 2020-04-24 | 2020-04-28 | 281,250 | $16.00 | $4.50M | 281,250 | SEC↗ |
| PRLD Prelude Therapeutics Inc | P Buy deriv | 2020-03-27 | 2020-09-30 | 3,681,822 | — | $0 | 7,363,644 | SEC↗ |
| ETNB 89bio, Inc. | C Conversion deriv | 2019-11-13 | 2019-11-13 | 7,944,444 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | C Conversion deriv | 2019-11-13 | 2019-11-13 | 7,944,444 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | C Conversion | 2019-11-13 | 2019-11-13 | 1,277,858 | — | $0 | 2,002,221 | SEC↗ |
| ETNB 89bio, Inc. | C Conversion | 2019-11-13 | 2019-11-13 | 1,277,858 | — | $0 | 2,002,221 | SEC↗ |
| ETNB 89bio, Inc. | P Buy | 2019-11-11 | 2019-11-13 | 418,750 | $16.00 | $6.70M | 724,363 | SEC↗ |
| ETNB 89bio, Inc. | P Buy | 2019-11-11 | 2019-11-13 | 418,750 | $16.00 | $6.70M | 724,363 | SEC↗ |
| SWTX SpringWorks Therapeutics, | C Conversion deriv | 2019-09-17 | 2019-09-19 | 6,078,103 | — | $0 | 0 | SEC↗ |
| SWTX SpringWorks Therapeutics, | C Conversion deriv | 2019-09-17 | 2019-09-19 | 1,053,204 | — | $0 | 0 | SEC↗ |
| SWTX SpringWorks Therapeutics, | C Conversion | 2019-09-17 | 2019-09-19 | 6,078,103 | — | $0 | 6,078,103 | SEC↗ |
| SWTX SpringWorks Therapeutics, | C Conversion | 2019-09-17 | 2019-09-19 | 1,053,204 | — | $0 | 7,131,307 | SEC↗ |
| SWTX SpringWorks Therapeutics, | P Buy | 2019-09-17 | 2019-09-19 | 275,000 | $18.00 | $4.95M | 7,406,307 | SEC↗ |
| PRVL Prevail Therapeutics Inc. | C Conversion deriv | 2019-06-24 | 2019-06-26 | 6,399,000 | — | $0 | 0 | SEC↗ |
| PRVL Prevail Therapeutics Inc. | C Conversion deriv | 2019-06-24 | 2019-06-26 | 1,011,499 | — | $0 | 0 | SEC↗ |
| PRVL Prevail Therapeutics Inc. | C Conversion deriv | 2019-06-24 | 2019-06-26 | 3,099,612 | — | $0 | 0 | SEC↗ |
| PRVL Prevail Therapeutics Inc. | C Conversion | 2019-06-24 | 2019-06-26 | 10,510,111 | — | $0 | 12,940,111 | SEC↗ |
| PRVL Prevail Therapeutics Inc. | P Buy | 2019-06-24 | 2019-06-26 | 882,352 | $17.00 | $15.00M | 13,822,463 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion deriv | 2019-05-13 | 2019-05-13 | 5,970,000 | — | $0 | 0 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion deriv | 2019-05-13 | 2019-05-13 | 3,554,466 | — | $0 | 0 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion deriv | 2019-05-13 | 2019-05-13 | 5,861,455 | — | $0 | 0 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion deriv | 2019-05-13 | 2019-05-13 | 3,582,000 | — | $0 | 0 | SEC↗ |
| NXTC NextCure, Inc. | P Buy | 2019-05-13 | 2019-05-13 | 350,000 | $15.00 | $5.25M | 2,711,013 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion | 2019-05-13 | 2019-05-13 | 442,438 | — | $0 | 2,361,013 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion | 2019-05-13 | 2019-05-13 | 445,866 | — | $0 | 445,866 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion | 2019-05-13 | 2019-05-13 | 743,110 | — | $0 | 1,188,976 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion | 2019-05-13 | 2019-05-13 | 729,599 | — | $0 | 1,918,575 | SEC↗ |
| TPTX Turning Point Therapeutics | C Conversion deriv | 2019-04-22 | 2019-04-24 | 2,105,259 | — | $0 | 0 | SEC↗ |
| TPTX Turning Point Therapeutics | C Conversion deriv | 2019-04-22 | 2019-04-24 | 4,314,809 | — | $0 | 0 | SEC↗ |
| TPTX Turning Point Therapeutics | C Conversion | 2019-04-22 | 2019-04-24 | 546,820 | — | $0 | 1,667,550 | SEC↗ |
| TPTX Turning Point Therapeutics | P Buy | 2019-04-22 | 2019-04-24 | 360,000 | $18.00 | $6.48M | 2,027,550 | SEC↗ |
| TPTX Turning Point Therapeutics | C Conversion | 2019-04-22 | 2019-04-24 | 1,120,730 | — | $0 | 1,120,730 | SEC↗ |
| AVDR AVEDRO INC | C Conversion deriv | 2019-02-19 | 2019-02-19 | 3,370,786 | — | $0 | 0 | SEC↗ |
| AVDR AVEDRO INC | C Conversion deriv | 2019-02-19 | 2019-02-19 | 383,746 | — | $0 | 0 | SEC↗ |
| AVDR AVEDRO INC | C Conversion deriv | 2019-02-19 | 2019-02-19 | 333,178 | — | $0 | 0 | SEC↗ |
| AVDR AVEDRO INC | C Conversion | 2019-02-19 | 2019-02-19 | 383,746 | — | $0 | 4,240,128 | SEC↗ |
| AVDR AVEDRO INC | C Conversion | 2019-02-19 | 2019-02-19 | 3,370,786 | — | $0 | 3,523,204 | SEC↗ |